Parkinson's disease: a review from pathophysiology to treatment

BLB Marino, LR de Souza, K Sousa… - Mini reviews in …, 2020 - ingentaconnect.com
Parkinson's Disease (PD) is the second most common neurodegenerative disease in the
elderly population, with a higher prevalence in men, independent of race and social class; it …

The synaptic vesicle glycoprotein 2: structure, function, and disease relevance

KA Stout, AR Dunn, C Hoffman… - ACS Chemical …, 2019 - ACS Publications
The synaptic vesicle glycoprotein 2 (SV2) family is comprised of three paralogues: SV2A,
SV2B, and SV2C. In vertebrates, SV2s are 12-transmembrane proteins present on every …

The dopamine transporter gene SLC6A3: multidisease risks

MEA Reith, S Kortagere, CE Wiers, H Sun… - Molecular …, 2022 - nature.com
The human dopamine transporter gene SLC6A3 has been consistently implicated in several
neuropsychiatric diseases but the disease mechanism remains elusive. In this risk synthesis …

Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management

CK Bhusal, DE Uti, D Mukherjee, T Alqahtani… - Parkinsonism & Related …, 2023 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the
progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta …

Movement disorder and neurotoxicity induced by chronic exposure to microcystin-LR in mice

M Yan, H Jin, C Pan, H Hang, D Li, X Han - Molecular Neurobiology, 2022 - Springer
Microcystins are produced by some species of cyanobacteria, which are hazardous
materials to the environment and human beings. It has been demonstrated that microcystin …

Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management

J Faouzi, JC Corvol, LL Mariani - Current Opinion in Neurology, 2021 - journals.lww.com
Impulse control disorders and related behaviors in Parkinson... : Current Opinion in Neurology
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and …

The genetic basis of multiple system atrophy

FS Tseng, JQX Foo, AS Mai, EK Tan - Journal of Translational Medicine, 2023 - Springer
Multiple system atrophy (MSA) is a heterogenous, uniformly fatal neurodegenerative ɑ-
synucleinopathy. Patients present with varying degrees of dysautonomia, parkinsonism …

Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease—a meta-analysis

Y Yin, Y Liu, M Xu, XM Zhang, C Li - Neurological Sciences, 2021 - Springer
Background and purpose Polymorphisms of the catechol-O-methyl transferase (COMT) or
monoamine oxidase B (MAO-B) genes may affect the occurrence of dyskinesia in …

[HTML][HTML] Impulse control disorders in Parkinson's disease: From bench to bedside

A Augustine, CA Winstanley, V Krishnan - Frontiers in Neuroscience, 2021 - frontiersin.org
Parkinson's disease (PD) is a neurodegenerative disorder that is characterized by symptoms
that impact both motor and non-motor domains. Outside of motor impairments, PD patients …

Psychosis in Parkinson's Disease: A Lesson from Genetics

E Angelopoulou, A Bougea, SG Papageorgiou, C Villa - Genes, 2022 - mdpi.com
Psychosis in Parkinson's disease (PDP) represents a common and debilitating condition that
complicates Parkinson's disease (PD), mainly in the later stages. The spectrum of psychotic …